Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
about
Airborne transmission of highly pathogenic H7N1 influenza virus in ferretsTwo years after pandemic influenza A/2009/H1N1: what have we learned?Continued dominance of pandemic A(H1N1) 2009 influenza in Victoria, Australia in 2010Long-term respiratory follow-up of H1N1 infection.Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysisOseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010.Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients.The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infectionsComparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses.Genome rearrangement of influenza virus for anti-viral drug screeningDetermination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrateCharacteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant RecipientOseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approachA Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil.Susceptibility of influenza A(H1N1)/pdm2009, seasonal A(H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014.Biological Evaluation of Uridine Derivatives of 2-Deoxy Sugars as Potential Antiviral Compounds against Influenza A Virus.Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors.
P2860
Q28387714-D8C130A4-88E8-4A75-A67A-2B0ED01EEF9FQ30224656-5C30A818-F306-4930-AD98-F10435D4CB43Q30352552-FB39048F-DFC3-402D-8B30-1C719795A5B3Q30404200-60903A30-5C49-411A-8D44-84595F290D6BQ30404485-C3AEA706-CC64-4F05-B607-B6C62D562D75Q30408174-4A728166-E8A2-4D9B-B8A9-497DE774C08DQ30410097-C2D638EF-A58E-460B-8D69-36146A7EB83CQ30410229-415ABBA6-5034-4AAB-ABE3-425D00BA731EQ30414319-E5B82D7B-E1CA-4884-B325-ACF7FF2D9F7AQ30419391-B3D6AEB6-47C6-4A3F-A28C-441BA30AE138Q30428311-45922E55-FD58-401A-AC33-08CCE1F36652Q34053717-4657F187-0E21-4369-9BFE-A764D679E97CQ34971083-D2E65486-A8A9-4D7D-A203-92A66A58596EQ36048315-411B467F-AD7F-477A-ACD0-775F4C0DF63FQ36175398-064F656E-D9AE-4EAB-9307-2EBAFB26A495Q36250190-F252D39D-9248-433A-8A7F-E2FC0A2DD345Q36593645-3EDC48AE-B3BB-40B8-BB3C-B0C1927A7AA5Q37582475-CE9176DF-005A-4F49-818A-264B02C010B8Q38209673-F8AED388-BFBA-4073-97FD-4BABC9EA5ED0Q39092470-E7B4434B-D40C-4B00-9DF7-36EC092E6362Q40080758-F3917093-B066-4843-98A6-15D8962FAA6AQ40094706-680E0FAC-7175-4896-882F-258987E4147BQ40814391-F1D43A36-F50F-4146-98D6-F904607A7F6B
P2860
Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Oseltamivir-resistant influenz ...... ion, March 2009 to March 2010.
@ast
Oseltamivir-resistant influenz ...... ion, March 2009 to March 2010.
@en
type
label
Oseltamivir-resistant influenz ...... ion, March 2009 to March 2010.
@ast
Oseltamivir-resistant influenz ...... ion, March 2009 to March 2010.
@en
prefLabel
Oseltamivir-resistant influenz ...... ion, March 2009 to March 2010.
@ast
Oseltamivir-resistant influenz ...... ion, March 2009 to March 2010.
@en
P2093
P1433
P1476
Oseltamivir-resistant influenz ...... gion, March 2009 to March 2010
@en
P2093
A R Tramontana
N Caldwell
N Komadina
P Iannello
P304
P577
2011-01-20T00:00:00Z